Posts With Tag NASDAQ TNXP

Explore Tonix Pharmaceuticals Holding Corp.'s latest 8-K report detailing significant events affecting TNXP. Key insights as of February 20, 2025, for investors and stakeholders.

Explore Tonix Pharmaceuticals' latest 8-K filing from January 8, 2025, detailing crucial updates on TNXP stock and financial metrics. Essential reading for investors!

Explore key insights from Tonix Pharmaceuticals' 8-K report dated December 17, 2024, detailing financial metrics, market position, and contact information for stakeholders.